Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Phase III Clinical Trial News Monitoring

Get by Email • RSS

Published on Jun 11, 2025

Small-Scale Study Highlights Positive Impacts of Once-Nightly Sodium Oxybate on Sleep-Related Eating Disorder

Using retrospective chart reviews, findings from a small-scale, single-site analysis revealed that switching treatment to once-nightly sodium oxybate (Lumryz; Avadel Pharmaceuticals) was associated with improvements in sleep-related eating disorder (SRED) …

Source: NeurologyLive - Pending
Published on Jun 11, 2025

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on Jun 11, 2025

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Abivax Announces Results of its June 6, 2025 Annual General Meeting PARIS, France, June 11, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on Jun 11, 2025

Healthcare companies chase cures and capital in South Florida

Leaders of hundreds of public healthcare companies are in South Florida this week, talking up their innovations and financial performances to attract and impress investors at the Goldman Sachs Global Healthcare Conference. Consumers will find that nearly …

Source: South Florida Sun Sentinel - Neutral
Published on Jun 11, 2025

Participants Discuss Optimal Immunotherapy Choices for Metastatic NPC

Treatment trends are evolving in the use of PD-1 inhibitors for recurrent or metastatic nasopharyngeal cancer (NPC). Event participants from across the Pacific region shared their diverse clinical experiences with Deborah Wong, MD, PhD, associate clinical …

Source: Targeted Oncology - Pending
Published on Jun 11, 2025

The Role of Liquid Biopsies in Precision Approaches for Breast Cancer Therapy

A rapidly expanding arsenal of molecularly targeted therapeutic approaches has improved breast cancer outcomes in both early-stage and advanced disease and supported the development of treatment approaches that tailor treatment intensity to individual …

Source: OncLive - Pending
Published on Jun 11, 2025

DESTINY-Breast09 and Ongoing Trials Underscore Shifting ADC Landscape in HER2+ Breast Cancer

Results from the phase 3 DESTINY-Breast09 trial (NCT04784715) highlight the increasing push to bring antibody-drug conjugate (ADC)–based regimens into earlier lines of HER2-positive breast cancer management, with fam-trastuzumab deruxtecan-nxki (T-DXd; …

Source: OncLive - Pending
Published on Jun 11, 2025

Phase 1 Data Pave the Way for Further Investigation of IMA203 in Advanced Melanoma

Following promising data regarding treatment with the PRAME-targeted T-cell receptor [TCR] T-cell therapy IMA203in patients with advanced or metastatic melanoma in the phase 1 ACTengine trial (NCT03686124), the phase 3 SUPRAME trial (NCT06743126) could …

Source: OncLive - Pending
Published on Jun 11, 2025

FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer

The U.S. Food and Drug Administration (FDA) has accepted the supplemental new drug application of Zepzelca (lurbinectedin) plus Tecentriq (atezolizumab) as a first-line maintenance treatment for people with extensive-stage small cell lung cancer whose …

Source: Cure Today - Neutral
Published on Jun 11, 2025

Bayesian Statistical Analysis (BSA) Demonstration Project

CDER Center for Clinical Trial Innovation (C3TI) C3TI aims to increase the use and understanding of Bayesian statistical methods in simple clinical trial settings across sponsors, CDER clinical reviewers, and CDER statisticians. The Bayesian Statistical …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on Jun 11, 2025

Moleculin Participates in Virtual Investor “What This Means” Segment

Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) Watch …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 11, 2025

OS Data From CARTITUDE-1: A Cure for Myeloma?

CHICAGO — The anticipated release of 5-year overall survival (OS) data from the CARTITUDE-1 trial showed that the use of ciltacabtagene autoleucel (cilta-cel) in patients with relapsed or refractory multiple myeloma (RRMM) met or exceeded expectations. “We …

Source: Medscape - Neutral
Published on Jun 11, 2025

Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.

WILLOWBROOK, Ill., June 11, 2025 (GLOBE NEWSWIRE) -- Pharmazz, Inc. ("Pharmazz" or the "Company"), a late-stage biopharmaceutical company developing innovative therapies for unmet medical needs in critical care and neurology, has …

Distribution channels: Banking, Finance & Investment Industry, Technology ...
Published on Jun 11, 2025

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic ...

SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 11, 2025

VivaVision Biotech Receives Positive FDA Feedback on VVN461LD Development for Postoperative Inflammation

VivaVision Biotech has announced encouraging written preliminary comments from the U.S. Food and Drug Administration (FDA) in advance of a planned Type C meeting, originally scheduled for early June 2025. The comments relate to the development of VVN461LD, …

Source: Ophthalmology Breaking News - Neutral
Published on Jun 11, 2025

Intensity Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock

(MENAFN- PR Newswire) SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS ) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and …

Source: MENAFN - Indeterminate
Published on Jun 12, 2025

Biliary Tract Cancer Market Size In The 7MM Was ~USD 1000 Million In 2023 And Is Expected To Increase A Significant CAGR ...

(MENAFN- GetNews) DelveInsight's“ Biliary Tract Cancer Treatment Market Insights, Epidemiology, and Market Forecast – 2034 ” report delivers an in-depth understanding of Biliary Tract Cancer, historical and forecasted epidemiology, as well as the …

Source: MENAFN - Indeterminate
Published on Jun 11, 2025

VivaVision Biotech receives positive preliminary comments from FDA on development of VVN461LD

VivaVision Biotech announced it has received written preliminary comments for the Type C meeting to be held in early June 2025 with the US Food and Drug Administration (FDA). According to the company, the FDA’s comments were positive regarding the …

Source: Ophthalmology Times - Pending
Published on Jun 10, 2025

FDA to review new oral gonorrhea antibiotic

Drugmaker Innoviva Specialty Therapeutics announced today that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for zoliflodacin, an investigational oral antibiotic for uncomplicated gonorrhea. If the FDA approves the …

Source: CIDRAP - Neutral

16 days 18:45:10

Featured Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 14:33 GMT

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:33 GMT

WST 重要截止日期：全美審訊法律顧問 ROSEN 鼓勵損失 10 萬美元以上的 West Pharmaceutical Services, Inc. 投資者在對 WST 提出證券集體訴訟的重要截止日期前聘請律師

紐約, June 15, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2023 年 2 月 16 日至 2025 年 2 月 12 日（包括首尾兩日，下稱「集體訴訟期」）期間購買了 West Pharmaceutical Services, Inc. (NYSE: WST) 普通股之人士注意，重要的首席原告截止日期為 2025 年 7 月 7 日。影響：如果您在集體訴訟期間購買 West …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:00 GMT

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

Distribution channels: Healthcare & Pharmaceuticals Industry

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 822,431,855 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 12:13 GMT

Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21

Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- In a time when public health and …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights

Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Mucopolysaccharidosis type I (MPS I) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly

New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Hunter Syndrome ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 04:30 GMT

Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser

ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /⁨EINPresswire.com⁩/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 03:00 GMT

Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices

New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Tom Jackobs, international sales strategist, is now offering …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 15, 2025 - 14:45 GMT

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in ...

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:00 GMT

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

RCP statement on Air India crash

RCP president, Dr Mumtaz Patel, said: ‘We are devastated by the plane crash in India today and the many lives it has claimed. Our thoughts and prayers are with everyone affected by this tragic incident. ‘We are directly contacting all our RCP members in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

Latest ‘Focus on physicians’ survey closes with over 2000 responses from doctors across the UK

The 2025 ‘Focus on physicians’ survey – a joint project between the Royal College of Physicians (RCP), the Royal College of Physicians and Surgeons of Glasgow (RCPSG) and the Royal College of Physicians of Edinburgh (RCPE) – has now closed. The ‘Focus on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 15, 2025 - 11:11 GMT

D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth

Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …

Distribution channels:
Published on June 14, 2025 - 16:42 GMT

Blue Sky Scrubs Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet

Blue Sky Medical Scrubs and Scrub Caps Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet AUSTIN, TX, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- In celebration of World Wind Day, Blue Sky Scrubs proudly joins the …

Distribution channels: Culture, Society & Lifestyle, Environment ...
Published on June 14, 2025 - 16:38 GMT

Cherry Blossoms and The Other Side, A Poetic Journey Through Grief and Beyond

LAWRENCE, MA, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- Acclaimed writer and visual dramatist Dennis Mullings presents a powerful double release with Cherry Blossoms and The Other Side, two moving and visually arresting plays that navigate the …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on June 14, 2025 - 16:28 GMT

ICN elects new President, José Luis Cobos Serrano and a new Board of Directors

ICN announces Dr José Luis Cobos Serrano as its 30th President at its Congress in Helsinki HELSINKI, FINLAND, June 14, 2025 /⁨EINPresswire.com⁩/ -- At the closing ceremony of ICN Congress 2025, ICN announced that it has elected Dr José Luis Cobos …

Distribution channels: Healthcare & Pharmaceuticals Industry, Human Rights ...
Published on June 14, 2025 - 14:48 GMT

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in ...

77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week 52 Data further support barzolvolimab clinical benefit to patients with CSU HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 14, 2025 - 14:42 GMT

ThinkCareBelieve: Week 21 of America's Progress under President Trump

Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here: https://thinkcarebelieve.blog/2025/06/14/week-21-of-americas-progress-under-president-trump/ ThinkCareBelieve has published an article on the …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 20:47 GMT

Proactive MD Announces Expansion into North Dakota and Utah

Healthcare innovator accelerates national growth with new access points SALT LAKE CITY, UT, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Proactive MD®, national leader in value-based care, announced the acquisition of multiple advanced …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 19:25 GMT

Ion Gel ZCM-25®: Innovador Avance Contra Infecciones por Bacterias Multirresistentes

Nuevo estudio muestra que Ion Gel ZCM-25® elimina hasta 93.5% de Acinetobacter baumannii en minutos, sin efectos adversos reportados. MEXICO, June 13, 2025 /⁨EINPresswire.com⁩/ -- Ion Gel ZCM-25®: Un Avance Prometedor Contra la Bacteria …

Distribution channels: Chemical Industry, Education ...
Published on June 13, 2025 - 17:56 GMT

Parkwood Home Care Continues to Honor Veterans Through Established Veterans CARE Program

Parkwood Home Care provides tailored, compassionate in-home care to veterans through the Veterans CARE Program, now celebrating seven years of service. HALIFAX, NOVA SCOTIA, CANADA, June 13, 2025 /⁨EINPresswire.com⁩/ -- Parkwood Home Care is proud …

Distribution channels: Business & Economy, Companies ...